Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Characterization of the NT2-derived neuronal and astrocytic cell lines as alternative in vitro models for primary human neurons and astrocytes.
Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions.
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
Macular spectral domain optical coherence tomography findings in Tanzanian endemic optic neuropathy.
Impact of mast cells on multiple sclerosis: inhibitory effect of natalizumab.
The Use of Agmatine Provides the New Insight in an Experimental Model of Multiple Sclerosis.
Collateral benefit: the comeback of MOG antibodies as a biomarker in neurological practice.
Cord blood mononuclear cells prevent neuronal apoptosis in response to perinatal asphyxia in the newborn lamb.
Axon damage in central nervous system and peripheral nervous system inflammatory demyelinating diseases: common and divergent pathways of dysfunction and tissue damage.
Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors.
Nanovesicle-based platform for the electrophysiological monitoring of aquaporin-4 and the real-time detection of its antibody.
[Current concepts on intrathecal humoral immune response and diagnostic importance of oligoclonal immunoglobulins in multiple sclerosis].
Central nervous system infiltrates are characterized by features of ongoing B cell-related immune activity in MP4-induced experimental autoimmune encephalomyelitis.
Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks.
Fibroblast Growth Factor-2 Signaling in Neurogenesis and Neurodegeneration.
Paradoxical Effect of Cortistatin Treatment and Its Deficiency on Experimental Autoimmune Encephalomyelitis.
Axonal expression of sodium channels and neuropathology of the plaques in multiple sclerosis.
Epigenetic mechanisms in neurological and neurodegenerative diseases.
The economic impact of multiple sclerosis in Australia in 2010.
Inequalities In Access to Treatment for Multiple Sclerosis In England Continue Despite Service Improvement Initiatives And Policy Reforms.
POEMS Syndrome in a Juvenile Initially Diagnosed as Treatment Resistant Chronic Inflammatory Demyelinating Polyneuropathy.
Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ?
Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives.
The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis?
New opportunities of real world data from clinical routine settings in life cycle-management of drugs: example of an integrative approach in multiple sclerosis.

Pages